A. Pendás
Cancer Research · 2004–2005
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 22 citations into it
- Molecular Biology — 16 citations into it
- Oncology — 13 citations into it
Whom A. Pendás trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from A. Pendás's perspective
Ordered by how strongly the researchers A. Pendás trusts endorse each paper. Same corpus, a different order for every researcher.
- Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry (Circulation Research)
- Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks (Nature Cell Biology)
- Matrix metalloproteinases: effectors of development and normal physiology. (Genes & Development)
- Lamin A Truncation in Hutchinson-Gilford Progeria (Science)
- Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
- New functions for the matrix metalloproteinases in cancer progression (Nature Reviews. Cancer)
- PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. (Cell)
- How matrix metalloproteinases regulate cell behavior. (Annual Review of Cell and Developmental Biology)
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations (Science)
- Development of matrix metalloproteinase inhibitors in cancer therapy. (Journal of the National Cancer Institute)
Their papers
- Genomic instability in laminopathy-based premature aging (2005) — 660 citations
- Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. (2004) — 610 citations